Your browser doesn't support javascript.
loading
This is a call to oncologists for action
Micó, C; Berrocal, A; Blasco, A; Caballero, C; Iranzo, V; Lobo, M; Camps, C.
Afiliación
  • Micó, C; University of Valencia. Faculty of Pharmacy. Department of Pharmacology. Valencia. Spain
  • Berrocal, A; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
  • Blasco, A; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
  • Caballero, C; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
  • Iranzo, V; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
  • Lobo, M; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
  • Camps, C; Hospital General Universitario de Valencia. Medical Oncology Department. Valencia. Spain
Clin. transl. oncol. (Print) ; 20(12): 1493-1501, dic. 2018. tab
Article en En | IBECS | ID: ibc-173756
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
Cancer cases are growing in an exponential way, likewise the prices of new cancer drugs. Continuing in this way, in the near future, it will be impossible to provide optimum care for all cancer patients. Therefore, it is important to establish mechanisms that enable the National Health Systems to provide the best options of treatment, either through the elaboration of decision-binding frameworks or through other initiatives that guarantee the best quality care for all oncology patients to overcome, in the best possible way, this difficult illness. Here, we review current proposals that have been established by different cancer organizations worldwide, their similarities, their differences and whether they are helpful in a real clinical setting. Facing present reality and despite these organizations’ huge efforts, these proposals are not being implemented at all and it does not seem feasible that they will in the short run. In the same way, we support and argue why oncologists should have a crucial and a preponderant role to establish the best way of guaranteeing an equal access to the latest oncology care
RESUMEN
No disponible
Asunto(s)
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Tecnología de Alto Costo / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Tecnología de Alto Costo / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article